Clinical Trial Update: Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting that a Phase 2/3 study evaluating nifuroxazide for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Nifuroxazide (nifuroxazide)

Snippet

Sponsor: Mostafa Bahaa | Conditions: Inflammatory Bowel Diseases | Phase 2, Phase 3 | Status: COMPLETED